Episode 46
E46: Atul Rustgi of Accolade on What is LP Value-Add and Can it Lead to Alpha?
How I Invest with David Weisburd
February 29, 202428m 46s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Atul Rustgi sits down with David Weisburd to discuss his role as a GP & LP, the paradoxes of selling and building relationships in VC, and the strategy of focusing on funds under $100 million. They also delve into including biotech as a diversification strategy, the importance of blockchain and crypto exposure, family office investments, and the challenges and rewards of raising a fund during a market downturn.
(0:00) Episode Preview
(0:45) Introduction of Guest - Atul Rustgi: Role and Responsibilities as a GP
(3:30) Discussion on the Paradoxes of Selling and Relationship Building in VC
(6:03) Strategy Behind Focusing on Funds Under $100 Million and the Math Behind Ownership
(11:14) Biotech as a Means to Diversify and Generate Alpha in VC
(16:01) Sponsor: Deel
(16:43) Blockchain and Crypto: The Importance of Exposure
(21:03) Family Office Direct Investments and The Value of Reference Calls
(24:57) Raising a Fund During a Market Downturn: Challenges and Rewards
(26:17) 10X Capital Podcast Newsletter
(26:42) Lessons Learned from a Long Career in Venture Capital by Atul Rustgi